Breast Health and Genetics: Understanding the BRCA gene.

When people in Singapore think about breast health, the conversation often starts with screening, self-awareness, and family history. For some families, however, the more important question is whether a genetic factor could be increasing risk. The BRCA1 and BRCA2 genes are among the most well-known inherited cancer risk genes, and understanding them can help people make informed decisions about prevention, screening, and when to seek medical advice. This matters not only for those with a strong family history of breast or ovarian cancer, but also for anyone who wants to understand how genetics fits into long-term health planning.

BRCA is short for breast cancer susceptibility gene. Everyone has BRCA1 and BRCA2 genes, and their normal role is to help repair damaged DNA. When these genes contain certain harmful changes, called pathogenic variants or mutations, the body may have a harder time repairing DNA properly. Over time, this can increase the risk of several cancers, especially breast and ovarian cancer. Importantly, having a BRCA mutation does not mean a person will definitely develop cancer, but it does mean their lifetime risk may be higher than average and their screening needs may differ from the general population.

In Singapore, breast cancer remains a major public health concern, and many people wonder whether genetic testing is relevant for them. The answer depends on personal and family factors, not just age. A clear understanding of BRCA genetics can help individuals speak more confidently with a doctor, especially if there are concerns about early-onset breast cancer in the family, bilateral breast cancer, male breast cancer, ovarian cancer, or a strong pattern of related cancers across generations. With the right information, people can make decisions that support both peace of mind and timely medical care.

What the BRCA1 and BRCA2 genes do

BRCA1 and BRCA2 are tumour suppressor genes, which means they help prevent cells from growing out of control. Their main job is to support DNA repair, especially after damage caused by normal cell division or environmental exposures. When these genes work properly, they help maintain genomic stability, a term that refers to keeping the genetic material in cells intact and functioning normally. When a harmful variant is present, DNA repair may become less effective, and the chance of abnormal cell growth can rise.

The BRCA genes are not the only genes linked to inherited cancer risk, but they are among the best studied. A pathogenic BRCA variant can be inherited from either parent. It is not something that only comes from the mother’s side, and men can pass it on to their children. That is why family history on both sides matters when assessing risk. A person may inherit the variant and never develop cancer, yet still have a higher probability than someone without the variant.

Why a gene mutation matters

A gene mutation is a change in the DNA sequence. In the BRCA context, some changes have no known harmful effect, while others are classified as pathogenic or likely pathogenic because they disrupt the gene’s function. These are the changes that may significantly increase cancer risk. The presence of a pathogenic variant does not mean cancer is present, and it does not diagnose cancer. Instead, it indicates a predisposition, meaning a greater tendency to develop certain cancers over a lifetime.

This distinction is important because genetic risk is not the same as disease. People can use genetic information to plan more appropriate screening, discuss preventive options, and alert family members who may also want to consider testing. That is one reason genetic counselling is usually recommended before and after testing.

How BRCA-related risk affects breast and other cancers

BRCA mutations are most strongly associated with breast and ovarian cancer, but they can also be linked to increased risk of other cancers. For women, the concern often centres on breast cancer, including the possibility of cancer developing at a younger age or in both breasts. For some families, ovarian cancer may also appear in the history, which can be a key clue that a hereditary cancer syndrome may be present. In men, BRCA mutations can increase the risk of male breast cancer and may also be associated with prostate cancer risk, depending on the specific gene involved and the family pattern.

It is important to keep in mind that risk is influenced by more than one gene. Age, reproductive history, lifestyle factors, hormonal exposures, and other inherited or acquired factors all play a role. BRCA testing gives only one part of the picture, but it can be a very important part when the family history is suggestive. In practice, doctors assess the whole clinical context before recommending testing or surveillance.

BRCA1 versus BRCA2

Both BRCA1 and BRCA2 increase cancer risk, but they are not identical. In broad terms, BRCA1 is often associated with a higher likelihood of developing triple-negative breast cancer, a subtype that does not have oestrogen receptor, progesterone receptor, or HER2 expression. BRCA2 is also linked to breast cancer and ovarian cancer risk, and may be more commonly associated with male breast cancer and prostate cancer in some families. These are general patterns, not fixed rules, and a doctor will consider the full history rather than relying only on gene names.

Knowing which gene is involved can help guide the type of screening and risk-reduction discussion. For example, some patients may need earlier and more intensive breast imaging, while others may consider strategies to reduce ovarian cancer risk. The exact plan should be individualised, because age, completed childbearing, overall health, and personal preferences all matter.

Who should consider BRCA testing in Singapore

BRCA testing is not meant for everyone as a routine test. It is usually considered when personal or family history suggests a higher likelihood of inherited cancer risk. In Singapore, this often begins with a doctor taking a detailed family history that includes the type of cancer, the age of diagnosis, and whether the cancer occurred on the same side of the family. A referral to a genetic counsellor or specialist is often the next step if the history is concerning.

Testing may be especially relevant for people with breast cancer diagnosed at a younger age, people with ovarian, fallopian tube, or primary peritoneal cancer, those with multiple relatives affected by breast, ovarian, prostate, or pancreatic cancer, and those with a known family BRCA mutation. Men with a family history suggestive of hereditary cancer should also be assessed, because hereditary risk does not only affect women. Some individuals may also be considered for testing if their cancer pathology or ancestry pattern raises suspicion, but this is determined case by case.

What the consultation usually involves

Before testing, genetic counselling helps a person understand what the test can and cannot tell them. The discussion usually covers possible results, including a positive result, a negative result, or a variant of uncertain significance. A positive result means a pathogenic variant is found. A negative result may be reassuring, but it does not erase risk from family history or other factors. A variant of uncertain significance means the lab has found a change in the gene, but current evidence is not enough to say whether it is harmful.

This is where medical interpretation matters. A test result should not be read in isolation, because the clinical meaning depends on the broader context. In Singapore, people can ask their primary care doctor, oncologist, gynaecologist, or breast specialist about referral pathways for hereditary cancer assessment.

What happens if a BRCA mutation is found

A positive BRCA result can feel overwhelming at first, but it also opens the door to more proactive care. The first step is usually a structured discussion with a doctor or genetic counsellor to review personal risk and plan next steps. These may include enhanced screening, risk-reducing surgery in selected cases, or discussion of medications in some situations. The right approach depends on age, cancer history, reproductive plans, and personal values.

For breast health, enhanced surveillance may include earlier and more frequent imaging. In many settings, breast MRI is used in addition to mammography for higher-risk individuals because MRI can be more sensitive in detecting some cancers, especially in dense breast tissue. The timing and combination of tests should be guided by a doctor familiar with hereditary cancer risk. A woman with a BRCA mutation should not simply follow average-risk screening advice without individual assessment.

Risk-reducing options

Risk-reducing surgery is one option for some people with a pathogenic BRCA variant. This may include bilateral risk-reducing mastectomy, which lowers the chance of developing breast cancer, and risk-reducing salpingo-oophorectomy, which involves removal of the fallopian tubes and ovaries to reduce ovarian cancer risk. These are major decisions and are not appropriate for everyone. They require careful counselling about benefits, risks, recovery, fertility, menopause, and body image.

Some patients may also discuss medication-based risk reduction, depending on their risk profile and whether they have had cancer before. These choices should be guided by specialist advice, because the balance of benefit and side effects differs from person to person. The goal is not to encourage one standard answer, but to tailor prevention to the individual.

Practical implications for Singapore families

For Singaporeans, managing hereditary cancer risk often means balancing busy work schedules, caregiving responsibilities, and healthcare planning. Many people delay appointments because they feel well, but genetic risk is often silent until screening or symptoms reveal a problem. If there is a significant family history, it is wise to speak to a doctor early rather than waiting for symptoms. A planned approach can be easier to fit into daily life than an urgent response after a diagnosis.

Singapore’s healthcare system offers both public and private pathways for assessment, imaging, and specialist review. People can start with a polyclinic or family doctor if they want a referral to the appropriate specialist. Those already under follow-up for breast cancer or another related cancer can ask their oncology team whether genetic testing would change their management. Keeping a written family history, including ages at diagnosis and types of cancer, can make the consultation much more efficient.

How families can talk about genetic risk

Family discussions about cancer risk can be sensitive, but they are important. If one person is found to carry a pathogenic BRCA variant, first-degree relatives such as parents, siblings, and children may have a chance of carrying the same variant. This is why cascade testing, which means offering testing to relatives of an identified carrier, can be valuable. It allows other family members to understand their own risk and take action earlier if needed.

When discussing genetic risk at home, it helps to keep the language calm and factual. Avoid making assumptions that everyone will develop cancer. Instead, focus on what is known, what is not known, and what screening or prevention steps may help. In many families, a clear plan reduces anxiety more than avoidance does.

When to seek medical advice

Anyone with a strong family history of breast, ovarian, pancreatic, or related cancers should consider speaking to a doctor about hereditary cancer assessment. This is especially important if cancer occurred at a young age, if there are multiple affected relatives, or if a male family member had breast cancer. People who are already diagnosed with breast cancer may also wish to ask whether genetic testing could influence surgical decisions, treatment planning, or family counselling.

It is also appropriate to seek advice if breast symptoms appear, such as a new lump, nipple discharge, skin dimpling, persistent breast pain in one area, or a change in breast shape or skin. These symptoms do not automatically mean cancer, but they should be assessed promptly. Genetic risk does not replace ordinary breast health awareness. Both matter.

For most people, the best next step is not panic, but a structured conversation with a qualified clinician. Bring any available family history, ask whether genetic counselling is suitable, and clarify whether testing would change your screening or treatment plan. That practical approach is often the most helpful way to move from uncertainty to informed action.

Understanding the BRCA gene is ultimately about using medical knowledge to make better decisions, not about expecting the worst. For some Singapore families, genetic testing provides reassurance. For others, it identifies a need for closer monitoring or preventive care. In either case, the goal is the same, to support timely, evidence-based decisions that protect breast health over the long term.